Signifier Medical Technologies’ eXciteOSA Now Covered by Medicaid in South Carolina: Reaching a Wider Patient Population with Daytime Sleep Apnea Therapy

BOSTON, MA –Signifier Medical Technologies Limited (“Signifier”), a leader in medical technology for sleep-disordered breathing, is thrilled to announce that eXciteOSA therapy is now covered by South Carolina’s Healthy Connections Medicaid program. This significant milestone further broadens access to eXciteOSA’s revolutionary daytime therapy for obstructive sleep apnea, ensuring that more individuals can benefit from this innovative and effective treatment.

Sleep apnea affects millions of Americans, and if left untreated, can lead to severe health issues. eXciteOSA’s non-invasive daytime therapy has shown greater than 80% adherence, demonstrating the positive impact on the lives of those suffering from obstructive sleep apnea by offering an alternative to traditional night-time devices.

“We are thrilled that eXciteOSA is now covered by Medicaid in South Carolina,” states Akhil Tripathi, Director and Co-founder of Signifier. “This achievement represents a significant milestone in our mission to make high-quality sleep apnea care accessible to all individuals. We look forward to continuing to collaborate with Medicaid and healthcare providers to improve sleep health outcomes for patients across the state and the country.”

The decision by the South Carolina Department of Health and Human Services to cover eXciteOSA therapy through its Medicaid program underscores the importance of accessible, effective treatment options for sleep-disordered breathing. This coverage opens new doors for patients 18 and older who have previously had limited access to advanced treatments for obstructive sleep apnea. Recognizing the therapy’s potential to improve health outcomes and reduce overall healthcare costs, this decision marks a pivotal step towards inclusive healthcare.

Dr. Joshua Lennon states, “As a physician prescribing eXciteOSA, I’ve witnessed firsthand the transformative impact this therapy has had on my patients struggling with obstructive sleep apnea. With Medicaid coverage now available in South Carolina, I’m thrilled to see more individuals gaining access to this innovative solution.”

“Adding coverage of this new therapy aligns well with our agency’s mission to be boldly innovative in improving health and quality of life for South Carolinians,” states Robby Kerr, Director of Human and Health Services in South Carolina.

Signifier extends its gratitude to the South Carolina Department of Health and Human Services for their partnership in expanding access to obstructive sleep apnea therapy for Medicaid beneficiaries. The company continues to work closely with healthcare providers, payers, and patients to support the adoption and implementation of eXciteOSA therapy, ensuring that more individuals can experience its life-changing benefits.

About eXciteOSA®

eXciteOSA is a revolutionary daytime therapy for sleep-disordered breathing. Clinically proven to target a common root cause of OSA, eXciteOSA uses NMES to “exercise” the upper airway muscles, working the intrinsic and extrinsic tongue muscles to improve endurance and prevent airway collapse during sleep. Unlike other devices that are used while patients sleep, eXciteOSA is the first commercially available device used while awake.

Signifier is dedicated to engaging with the sleep research community to produce high-quality evidence from rigorous clinical trials.

To learn more about eXciteOSA, please visit or


Jay Cranston
Signifier Medical Technologies Limited
[email protected]

Investors and Partners:
Investor Relations
Signifier Medical Technologies Limited
[email protected]